Armatus Bio
2 known investors
Armatus Bio develops vectorized RNA interference therapeutics targeting genetic neurological and neuromuscular diseases.
BiotechMedical Devices
Investors · 2
Founder mafia
3 people who came through Armatus Bio went on to found or lead other companies.
Competitors · 7
by search overlapAgenus9 shared keywords
Totus Medicines5 shared keywordsTotus Medicines develops precision covalent small-molecule oral therapies aimed at historically "undruggable" and known disease targets, using its OmniDEL discovery platform that screens targets in their normal cellular environment. Its drug programs span oncology, immunology and inflammation, targeting patients with limited treatment options.
Arbutus Biopharma Corporation5 shared keywordsArbutus is a biotechnology company developing therapeutic assets and bringing them to market, with expertise spanning scientific, clinical, operational, and financial development. It focuses on drug development, partnerships, and licensing deals within the biopharma sector.
Talus Bio5 shared keywordsTalus develops a proprietary platform that measures and modulates the regulome—the body's gene expression control system—in native cellular contexts. The company designs AI-driven compounds and uses functional proteomics to enable drug discovery for transcription factors and regulatory proteins implicated in oncology, rare disease, and immune dysfunction.
Amicus Therapeutics4 shared keywordsAmicus is a rare disease biotechnology company developing medicines for people with genetically defined conditions. It operates as a wholly owned subsidiary of BioMarin Pharmaceutical Inc.
Emmaus Life Sciences4 shared keywordsEmmaus Life Sciences is a pharmaceutical company that develops and commercializes Endari (prescription-grade L-glutamine oral powder), an FDA-approved treatment for sickle cell disease, and pursues additional indications such as diverticulosis. The company sells and seeks marketing authorization for its products in the United States and internationally, including the Middle East and North Africa region.
Nautilus Biotechnology3 shared keywordsNautilus develops proteomics technology to unlock the complexity of the human proteome for biomedical research and diagnostics. The company targets pharmaceutical, biotechnology, academic, clinical, and government sectors with advanced protein quantification and analysis platforms.
Companies competing with Armatus Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Armatus Bio do?
- Armatus Bio develops vectorized RNA interference therapeutics targeting genetic neurological and neuromuscular diseases.
- Who are Armatus Bio's investors?
- Armatus Bio's investors include Angel Physicians Fund, CincyTech.